Millennium Management
THRX

Millennium Management’s Theseus Pharmaceuticals, Inc. Common Stock THRX Stock Holding History

Millennium Management’s Portfolio THRX Stock Details THRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-1,717,862
Closed -$4.62M – 6710
2023
Q3 		$4.62M Buy
1,717,862
+1,588,867
+1,232% +$6.23M ﹤0.01% 2772
2023
Q2 		$1.2M Buy
128,995
+48,960
+61% +$482K ﹤0.01% 3897
2023
Q1 		$711K Buy
+80,035
New +$786K ﹤0.01% 4374

Other funds holding THRX

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
FCMV
Foresite Capital Management V Larkspur, California $271M AUM 309.87% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return

Millennium Management's THRX Position: Q4 2023 in Review

Millennium Management sold out of Theseus Pharmaceuticals, Inc. Common Stock (THRX) in Q4 2023, closing a stake of 1,717,862 shares — an estimated $4.62M sold.

Millennium Management first reported a position in THRX in Q1 2023 and held it in 3 quarters. The position peaked at $4.62M in Q3 2023. 70 funds tracked by Wall St. Rank hold THRX as of Q4 2023.

  • Millennium Management reported no remaining Theseus Pharmaceuticals, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Millennium Management sold 1,717,862 Theseus Pharmaceuticals, Inc. Common Stock shares in Q4 2023, an estimated $4.62M.
  • Millennium Management first reported a position in Theseus Pharmaceuticals, Inc. Common Stock in Q1 2023 and held it in 3 quarters.
  • Millennium Management's Theseus Pharmaceuticals, Inc. Common Stock position peaked at $4.62M in Q3 2023.
  • 70 funds tracked by Wall St. Rank held Theseus Pharmaceuticals, Inc. Common Stock as of Q4 2023.

Based on Millennium Management's 13F filing for Q4 2023, filed 14 Feb 2024.